Shares of Fonar Corporation (NASDAQ:FONR - Get Free Report) passed above its 200-day moving average during trading on Tuesday . The stock has a 200-day moving average of $14.28 and traded as high as $15.87. Fonar shares last traded at $15.50, with a volume of 9,283 shares changing hands.
Analyst Ratings Changes
Separately, Wall Street Zen raised Fonar from a "buy" rating to a "strong-buy" rating in a research note on Saturday, July 26th.
Get Our Latest Report on FONR
Fonar Stock Performance
The company has a market cap of $96.72 million, a P/E ratio of 12.48 and a beta of 0.97. The firm has a 50 day moving average price of $15.64 and a two-hundred day moving average price of $14.28.
Institutional Inflows and Outflows
Several large investors have recently added to or reduced their stakes in FONR. Ritholtz Wealth Management bought a new position in Fonar in the 2nd quarter worth about $157,000. Empowered Funds LLC grew its position in Fonar by 7.7% during the 1st quarter. Empowered Funds LLC now owns 21,139 shares of the medical equipment provider's stock worth $296,000 after acquiring an additional 1,504 shares during the last quarter. Linden Thomas Advisory Services LLC increased its stake in shares of Fonar by 16.5% during the first quarter. Linden Thomas Advisory Services LLC now owns 34,054 shares of the medical equipment provider's stock valued at $477,000 after buying an additional 4,818 shares during the period. Bridgeway Capital Management LLC increased its stake in shares of Fonar by 1.2% during the fourth quarter. Bridgeway Capital Management LLC now owns 80,035 shares of the medical equipment provider's stock valued at $1,212,000 after buying an additional 945 shares during the period. Finally, Money Concepts Capital Corp boosted its position in shares of Fonar by 1.2% during the first quarter. Money Concepts Capital Corp now owns 406,296 shares of the medical equipment provider's stock valued at $5,692,000 after purchasing an additional 4,719 shares in the last quarter. Institutional investors own 50.64% of the company's stock.
Fonar Company Profile
(
Get Free Report)
FONAR Corporation, together with its subsidiaries, engages in the research, development, production, and marketing of magnetic resonance imaging (MRI) scanners for the detection and diagnosis of human diseases in the United States. The company operates in two segments, Medical Equipment, and Physician Management and Diagnostic Services.
See Also
Before you consider Fonar, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Fonar wasn't on the list.
While Fonar currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
